Losartan Potassium/Hydrochlorothiazide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Losartan Potassium/Hydrochlorothiazide, covering 2017-10-25 to 2017-10-25. Get the full timeline:
Most recent: Clinical Trial Update: Bioequivalence Study of Losartan Potassium and Hydrochlorothiazide (100 mg / 25 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Hyzaar® (100 mg / 25 mg Tablet) [Reference Formulation, Merck & Co., Inc., USA] in Healthy Human Volunteers Under Fasting Conditions. [Phase 1]